Abstract

Cytomegalovirus (CMV) infection is a matter of concern for blood bank professionals and blood transfusion recipients, especially in cases of transfusions to neonates and immunocompromised patients. Thus, the present study aimed to determine the seroprevalence of CMV IgG and IgM antibodies among blood donors in the city of Lages, in the mountain region of Santa Catarina, southern Brazil, and to investigate possible associations between the socioeconomic characteristics of donors and CMV serological status. A seroepidemiological cross-sectional study was conducted on 1,045 blood samples from donors that were used in serological screening over a one-year investigation. All the analyses were conducted using the microparticle enzyme immunoassay with Biokit(R) reagents (Barcelona, Spain), in accordance with the manufacturer's instructions. Anti-CMV IgG seroprevalence in the sample studied was 96.4% (95% CI: 95.23 - 97.50) and that of anti-CMV IgM was 2.3% (95% CI: 1.39 - 3.20). There were no statistically significant associations between the presence of antibodies and the socioeconomic characteristics of donors. The blood donors in the study region had high seroprevalence of anti-CMV IgG. Thus, blood component screening strategies and careful indication for blood transfusions require special attention among healthcare professionals as part of the actions for prevention and reduction of primary infections caused by CMV.

Highlights

  • Cytomegalovirus (CMV) infection is a matter for concern among blood bank professionals and blood transfusion recipients, especially in cases of transfusions to neonates and immunocompromised patients[1]

  • Brazilian Ministry of Health Resolution 153/04, which provides the technical regulations for blood therapy procedures, determines that CMV serological tests should be performed on all blood units or blood products that are to be transfused into CMV-seronegative patients undergoing organ transplants and newborns weighing less than 1,200 g at birth, from CMV-seronegative mothers or mothers of unknown serological status

  • Since no data on the seroprevalence of CMV antibodies among the population of the State of Santa Catarina exists, this study aimed to determine the seroprevalence of anti-CMV IgG and IgM among blood donors in the city of Lages, Santa Catarina, southern Brazil

Read more

Summary

Introduction

Cytomegalovirus (CMV) infection is a matter of concern for blood bank professionals and blood transfusion recipients, especially in cases of transfusions to neonates and immunocompromised patients. The present study aimed to determine the seroprevalence of CMV IgG and IgM antibodies among blood donors in the city of Lages, in the mountain region of Santa Catarina, southern Brazil, and to investigate possible associations between the socioeconomic characteristics of donors and CMV serological status. Brazilian Ministry of Health Resolution 153/04, which provides the technical regulations for blood therapy procedures, determines that CMV serological tests should be performed on all blood units or blood products that are to be transfused into CMV-seronegative patients undergoing organ transplants and newborns weighing less than 1,200 g at birth, from CMV-seronegative mothers or mothers of unknown serological status. These serological tests are not required if such patients are transfused with leukocyte-depleted blood products[6]

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call